Back to search
FDAFDA · Food and drugs·Recall number D-0065-2025

THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031

Published December 4, 2024 · Recall initiated: October 24, 2024

Summary

FDA records drug Class II recall D-0065-2025, published December 4, 2024 and initiated October 24, 2024. Recalling firm: Unexo Life Sciences Private Limited; Status: Terminated; Reported quantity: 455,536 patches; Lot: a) UPC 8 45717 00878 5 b) UPC 8 45717 01056 6. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
THERACARE MAXIMUM STRENGTH PAIN RELIEF PATCH
Manufacturer
Unexo Life Sciences Private Limited
Distributor
Nationwide in the US
UPC
845717008785
Lot
a) UPC 8 45717 00878 5 b) UPC 8 45717 01056 6
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031 recalled?

Yes. FDA published recall D-0065-2025 on December 4, 2024. Reported hazard: cGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: THERACARE MAXIMUM STRENGTH PAIN RELIEF PATCH. UPC: 845717008785.